TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 16, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Cash from Operations (2020 - 2023)

TFA Therapeutics (RAJAF) posted Cash from Operations of -$1.2 million for Q4 2023, down 568.9% on a QoQ basis from -$184290.0 in Q4 2022, and down 568.9% year-over-year from $262894.5 in Q4 2022.

Analysis

TFA Therapeutics (RAJAF) Cash from Operations (2020 - 2023) Analysis & Trends

TFA Therapeutics has reported Cash from Operations for 3 years, with the latest figure at -$1.2 million in Q4 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Colgate Palmolive 69.71 Bn 68.67 Bn 3.30 Bn 995.00 Mn
2 Kenvue 34.22 Bn 33.11 Bn 2.30 Bn 688.00 Mn
3 Kimberly Clark 32.55 Bn 31.72 Bn 1.60 Bn 908.00 Mn
4 Bath & Body Works 3.52 Bn 2.73 Bn 692.00 Mn -
5 Prestige Consumer Healthcare 2.52 Bn 2.46 Bn - -
6 Perrigo 1.88 Bn 1.49 Bn 313.90 Mn 82.60 Mn
7 Edgewell Personal Care 1.25 Bn 854.93 Mn 242.50 Mn 118.70 Mn
8 Herbalife 1.25 Bn 883.17 Mn 1.03 Bn 32.90 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Honest Company 611.15 Mn 505.26 Mn 40.36 Mn 32.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -1.23 Mn
Dec 31, 2022 -184,290.00
Dec 31, 2020 -130,549.00